|Articles|March 18, 2020 (Updated: November 15, 2020)
Three Key Critical Considerations Before Embarking on Decentralized Trials
Author(s)Oracle
- Clinical trials can be designed across a continuum of formats. - Adding decentralized elements to trials can help acquire high-quality data. - Sponsors must understand the impact across the trial landscape for success.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
3
FDA Approves Hernexeos Under National Priority Voucher Program
4
Leading in the Psychedelic Space: Q&A with Tarek Rabah
5